Monday, October 26, 2026 · Daily editionET --:--:--

Not recruiting yet

Robot Assisted Minimally Invasive Treatment Versus Conventional Surgery for FFP3-4 Fragility Fractures of the Pelvis in Elderly Patients

NCT07639619 · Junbo Liang · Updated 10 June 2026

What is being tested
Robot Assisted Minimally Invasive Fixation; Conventional Open Fixation
For
Fragility Fractures of the Pelvis (FFP); Osteoporosis
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 60 years and older. About 88 people. The full rules are on the registry page.
Where
China
When
Starts or started 1 June 2026, ends 30 Dec 2028. Registered 10 June 2026.
Results
None posted yet.

In the researchers' words

This prospective randomized controlled trial aims to compare the efficacy and safety of robot assisted minimally invasive treatment versus conventional surgery in elderly patients with FFP3-4 fragility fractures of the pelvis. Eligible patients will be stratified according to FFP classification and randomly assigned in a 1:1 ratio to receive either robot assisted minimally invasive fixation or conventional surgical treatment. Primary and secondary outcomes include pain relief, early mobilization, functional recovery, perioperative complications, venous thromboembolism events, laboratory parameters, imaging outcomes, and healthcare resource utilization. The study aims to provide evidence for optimizing surgical treatment strategies in elderly patients with unstable pelvic fragility fractures.
ClinicalTrials.gov, NCT07639619

Sites

  • No. 150 Ximen RoadLinhai, Zhejiang, China